Bill Anderson to become CEO of Bayer AG, effective June 1, 2023. He will join the Board of Management as of April 1. Our current CEO Werner Baumann will work closely with him on a smooth transition process before retiring from Bayer after 35 years of service at the end of May 2023. Bill Anderson, a chemical engineer by education, has served in various leadership positions in the biotech industry in the past 25 years. Most recently, he served as CEO of Roche’s Pharmaceuticals Division, where he successfully led a comprehensive transformation program, which resulted in significant revenue growth and many successful new product launches.